Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Active8: Motolimod in SCCHN
NCT01836029Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Oct 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of motolimod in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Celgene Corporation. Started Oct 2013; status: completed.
02
Drugs
motolimod
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01836029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01836029.